Lite Strategy Inc. Announces Director Changes

Ticker: LITS · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1262104

Lite Strategy, INC. 8-K Filing Summary
FieldDetail
CompanyLite Strategy, INC. (LITS)
Form Type8-K
Filed DateDec 30, 2025
Risk Levelmedium
Pages4
Reading Time4 min
Key Dollar Amounts$0.00000002, $575,000
Sentimentneutral

Sentiment: neutral

Topics: director-change, officer-compensation

TL;DR

Lite Strategy (fka MEI Pharma) swapped a director and is tweaking exec pay. Board changes are always worth watching.

AI Summary

Lite Strategy, Inc. (formerly MEI Pharma, Inc.) announced on December 23, 2025, the departure of Director Dr. Brian J. Fox and the appointment of Dr. David E. Johnson as a new director. The company also disclosed compensatory arrangements for certain officers, though specific details and dollar amounts are not provided in this excerpt.

Why It Matters

Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Director departures and changes in compensatory arrangements can indicate internal shifts or challenges within the company.

Key Players & Entities

FAQ

Who has departed from the board of directors at Lite Strategy, Inc.?

Dr. Brian J. Fox has departed from the board of directors.

Who has been appointed as a new director?

Dr. David E. Johnson has been appointed as a new director.

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported is dated December 23, 2025.

What was Lite Strategy, Inc. formerly known as?

Lite Strategy, Inc. was formerly known as MEI Pharma, Inc.

What is the principal business address of Lite Strategy, Inc.?

The principal business address is 9920 Pacific Heights Blvd., Suite 150, San Diego, California 92121.

Filing Stats: 1,122 words · 4 min read · ~4 pages · Grade level 11.9 · Accepted 2025-12-30 06:00:41

Key Financial Figures

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit Number Exhibit Title 10.1 Employment Agreement between the Company and Justin J. File, dated December 23, 2025 10.2 Employee Proprietary Information and Inventions Agreement between the Company and Justin J. File, dated December 23, 2025

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LITE STRATEGY, INC. Date: December 30, 2025 By: /s/ Justin J. File Justin J. File Chief Executive Officer, Chief Financial Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing